Showing results (51-60 of 126) with videos related to

Sort By:
Pageof 13
Plos One|July 11, 2013
Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin EKangsheng Tu, Xin Zheng, Zhenyu Zhou, et al.
Oncology Reports|February 18, 2016
BCL-3 promotes the tumor growth of hepatocellular carcinoma by regulating cell proliferation and the cell cycle through cyclin D1Kangsheng Tu, Zhikui Liu, Bowen Yao, et al.
Molecular Cancer|June 3, 2014
Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinomaKangsheng Tu, Wei Yang, Chao Li, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 30, 2014
PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptorsChunsheng Liu, Jiachu Li, Xiaoyu Xiang, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 31, 2016
Tanshinol suppresses cardiac allograft rejection in a murine modelChuanjian Lu, Yu-Qun Zeng, Huazhen Liu, et al.
BMC Cancer|February 17, 2016
BCORL1 is an independent prognostic marker and contributes to cell migration and invasion in human hepatocellular carcinomaGuozhi Yin, Zhikui Liu, Yufeng Wang, et al.
Cell Death & Disease|September 10, 2020
Bromodomain-containing protein 9 promotes the growth and metastasis of human hepatocellular carcinoma by activating the TUFT1/AKT pathwayChangwei Dou, Liankang Sun, Liang Wang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|December 14, 2017
Hypoxia Accelerates Aggressiveness of Hepatocellular Carcinoma Cells Involving Oxidative Stress, Epithelial-Mesenchymal Transition and Non-Canonical Hedgehog SignalingZhikui Liu, Kangsheng Tu, Yufeng Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 1, 2017
MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3CJie Tao, Zhikui Liu, Yufeng Wang, et al.
International Journal of Biological Sciences|July 25, 2019
miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418Liang Wang, Liankang Sun, Yufeng Wang, et al.
Pageof 13